CXApp Inc.
CXAI Nasdaq Services-Prepackaged Software Financials FY2021βFY2025
What CXApp Inc. does
No business description yet.
- Legal name
- CXApp Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 30, 2026
- Accession Β· CIK
- 0001829126-26-002840
0001820875
Revenue and margins
CXApp Inc. had $4.6M of revenue in fiscal 2025, down 35.8% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$10.4M in fiscal 2025, β227.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
CXApp Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably CXApp Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $0.4M | $0.2M | $6.3M | $4.9M | $11.1M |
| Interest coverage | β | β | β | β12.9x | β8,788.5x |
| Current ratio | 0.7x | 1.0x | 0.9x | 0.6x | 2.2x |
| Quick ratio | 0.7x | 1.0x | 0.9x | 0.6x | 2.2x |
| Total assets | $279M | $33.4M | $36.6M | $31.8M | $32.4M |
| Total liabilities | $21.7M | $9.8M | $11.2M | $16.2M | $18.4M |
| Shareholders' equity | β$21.1M | $23.6M | $25.4M | $15.6M | $14.0M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β |
| F-score | β / 3 | β / 6 | β / 3 | β / 5 | 4 / 7 |
| Accruals ratio | 3.5% | 5.8% | β | β35.3% | β9.6% |
| Altman Z'' | β1.31 | 1.59 | β | β10.74 | β10.53 |
5 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $0.1M | $0.4M | β | $7.1M | $4.6M |
| Net interest income | $0.1M | $0.4M | β | β$1.8M | β$0.7M |
| Gross profit | β | β | $5.6M | $5.9M | $4.0M |
| Research and development | β | β | β | $6.4M | $6.6M |
| Operating income | β$1.5M | β$3.0M | β | β$13.7M | β$17.6M |
| Interest expense | β | β | β | $1.1M | $0.0M |
| Pretax income | $9.2M | $8.4M | β | β$20.0M | β$13.5M |
| Income tax | β | $0.0M | β | β$0.6M | β$0.0M |
| Net income | $9.2M | $8.3M | β$53.6M | β$19.4M | β$13.5M |
| Net income to common | β | β | β$53.6M | β$19.4M | β$13.5M |
| Cash flow | |||||
| Cash from operations | β$0.6M | β$0.8M | β | β$7.3M | β$10.4M |
| Capital expenditure | β | β | β | $0.0M | $0.0M |
| Free cash flow | β | β | β | β$7.4M | β$10.4M |
| Depreciation and amortization | β | β | β | $0.1M | $0.0M |
| Share buybacks | β | $275M | β | β | β |
| Dividends and buybacks | β | $275M | β | β | β |
| Balance sheet | |||||
| Cash and short-term investments | $0.4M | $0.2M | $6.3M | $4.9M | $11.1M |
| Deposits | β | β | β | $4.4M | $10.7M |
| Current assets | $0.5M | $8.8M | $9.0M | $7.1M | $12.8M |
| Current liabilities | $0.8M | $8.6M | $10.3M | $11.6M | $5.8M |
| Property and equipment, net | β | β | β | $0.1M | $0.0M |
| Goodwill | β | β | β | $8.7M | $6.6M |
| Intangible assets | β | β | $18.1M | $15.4M | $12.7M |
| Total assets | $279M | $33.4M | $36.6M | $31.8M | $32.4M |
| Total liabilities | $21.7M | $9.8M | $11.2M | $16.2M | $18.4M |
| Preferred stock | $0.0M | $0.0M | β | β | β |
| Shareholders' equity | β$21.1M | $23.6M | $25.4M | $15.6M | $14.0M |
| Margins | |||||
| Gross margin | β | β | β | 82.0% | 87.4% |
| Operating margin | β2,193.1% | β700.0% | β | β192.4% | β383.5% |
| EBITDA margin | β | β | β | β191.3% | β382.5% |
| Net margin | 13,481.6% | 1,980.3% | β | β271.7% | β294.0% |
| FCF margin | β | β | β | β103.0% | β227.0% |
| Net interest share of revenue | 100.0% | 100.0% | β | β24.6% | β15.3% |
| Returns | |||||
| Return on capital employed | β0.5% | β11.9% | β | β67.9% | β65.9% |
| Return on equity | β | 668.5% | β218.9% | β94.7% | β91.1% |
| Return on assets | 3.3% | 5.3% | β153.2% | β56.8% | β42.0% |
| Return on tangible equity | β | 35.4% | β738.3% | β | β |
| Growth | |||||
| Revenue growth | β | 517.1% | β | β | β35.8% |
| Net income growth | β | β9.4% | β742.4% | β | β |
| Financial health | |||||
| Interest coverage | β | β | β | β12.9x | β8,788.5x |
| Current ratio | 0.7x | 1.0x | 0.9x | 0.6x | 2.2x |
| Quick ratio | 0.7x | 1.0x | 0.9x | 0.6x | 2.2x |
| Capital allocation | |||||
| Capex / revenue | β | β | β | 0.4% | 0.5% |
| Quality scores | |||||
| Piotroski F-score | β | β | β | β | 4.0 |
| Altman Z'' | β1.3 | 1.6 | β | β10.7 | β10.5 |
| Accruals ratio | 3.5% | 5.8% | β | β35.3% | β9.6% |
Source: SEC EDGAR XBRL filings (CIK 0001820875). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.